Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018)
Twist Bioscience (TWST) posted quarterly Preferred Stock Liabilities of $290.5 million for Q3 2018, up 690.95% quarter-over-quarter from $36.7 million in Q2 2018.
Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Twist Bioscience (TWST) has reported Preferred Stock Liabilities for 2 consecutive years, with $290.5 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $290.5 million; the TTM figure through Sep 2018 stood at $290.5 million (changed N/A YoY), while the FY2018 annual figure was $290.5 million, up 127.18% from the prior year.
- Preferred Stock Liabilities climbed to $290.5 million in Q3 2018 per TWST's latest filing, from $36.7 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $290.5 million in Q3 2018 and bottomed at $36.7 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 290.48 Mn |
| Jun 30, 2018 | 36.73 Mn |
| Mar 31, 2018 | 186.83 Mn |
| Dec 31, 2017 | 130.86 Mn |